type 2 diabetes

Hua Medicine May be Sending Type 2 Diabetes into Remission
BioSpace
Tue, 09/28/21 - 12:01 am
Hua Medicine
China
diabetes
type 2 diabetes
Artificial pancreases were a breakthrough for type 1 diabetes. The research in type 2 is just beginning
Stat
Wed, 08/4/21 - 10:37 pm
artificial pancreas
devices
diabetes
type 1 diabetes
type 2 diabetes
Wins for AstraZeneca: Diabetes Drug Approved for Teens, Covid Vaccine Effective against Delta Variant
BioSpace
Fri, 07/23/21 - 12:49 pm
AstraZeneca
type 2 diabetes
adolescents
Bydureon BCise
vaccines
Rivus’ fat-trimming therapy nabs $35M to harness our own biology against a host of diseases
Fierce Biotech
Tue, 07/20/21 - 12:27 pm
Rivus Pharmaceuticals
type 2 diabetes
NASH
hypertriglyceridemia
heart failure with preserved ejection fraction
Bayer's Farxiga rival Kerendia scores long-awaited kidney and heart disease nod for Type 2 diabetes patients
Fierce Pharma
Fri, 07/9/21 - 11:58 pm
Bayer
finerenone
Kerendia
kidney disease
heart disease
diabetes
type 2 diabetes
Farxiga
Dexcom’s CEO claims company has a ‘compelling’ case for broader CGM use
MedCity News
Wed, 06/30/21 - 10:10 pm
DexCom
devices
continuous glucose monitoring
diabetes
type 1 diabetes
type 2 diabetes
ADA 2021: Novo trumpets higher-dose Ozempic data as Lilly competitors loom
Fierce Pharma
Sun, 06/27/21 - 10:57 pm
Novo Nordisk
Ozempic
Eli Lilly
Rybelsus
Trulicity
diabetes
type 2 diabetes
ADA 2021: AstraZeneca touts Bydureon trial win in children and adolescents with type 2 diabetes
Fierce Pharma
Fri, 06/25/21 - 12:16 pm
AstraZeneca
Bydureon
diabetes
pediatric
type 2 diabetes
clinical trials
After a decade in the type 2 diabetes game, Fractyl Laboratories recharges with a fresh $100M and a new name
Endpoints
Wed, 06/16/21 - 11:45 am
Fractyl Labs
type 2 diabetes
diabetes
Will Fractyl be Successful in Eliminating the Need for Daily Insulin?
Medical Devices and Diagnostics Industry
Mon, 03/22/21 - 10:45 am
devices
Fractyl Labs
insulin
type 2 diabetes
Revita DMR
DMR
Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture
Fierce Biotech
Thu, 03/4/21 - 10:05 am
Eli Lilly
Novo Nordisk
tirzepatide
semaglutide
type 2 diabetes
clinical trials
Lilly's tirzepatide aces 2 more late-phase diabetes trials
Fierce Biotech
Wed, 02/17/21 - 11:01 am
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes
Yahoo/Global Newswire
Wed, 01/20/21 - 10:39 am
Novo Nordisk
FDA
Ozempic
type 2 diabetes
semaglutide
Lilly's Tirzepatide Significantly Reduced A1C and Body Weight in People with Type 2 Diabetes
Drugs.com
Tue, 12/15/20 - 08:24 pm
Eli Lilly
tirzepatide
clinical trials
type 2 diabetes
diabetes
Lilly's tirzepatide drives deep drops in blood sugar and body weight in diabetes phase 3
Fierce Biotech
Wed, 12/9/20 - 10:46 am
Eli Lilly
tirzepatide
type 2 diabetes
clinical trials
Dexcom takes no-fingerprick message to people with Type 2 diabetes in new TV ads
Fierce Pharma
Tue, 11/24/20 - 11:23 pm
DexCom
DTC advertising
diabetes
type 2 diabetes
blood glucose monitoring
Novo launches type 2 diabetes pill in UK after NICE waives review
Pharmaforum
Tue, 09/1/20 - 10:44 am
Novo Nordisk
UK
type 2 diabetes
diabetes
Rybelsus
semaglutide
NICE
Study: Type 2 Diabetes Treatments May Be More Effective When Combined
BioSpace
Sun, 08/30/20 - 11:27 pm
diabetes
type 2 diabetes
FGF21
GLP-1 agonist
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1 together helps control blood sugar
Fierce Pharma
Sun, 06/14/20 - 08:06 pm
ADA
diabetes
Sanofi
Soliqua
type 2 diabetes
Fractyl Seeks to Turn Diabetes On Its Ear with Revita DMR
Medical Devices and Diagnostics Industry
Thu, 06/11/20 - 12:13 pm
Fractyl Labs
diabetes
type 2 diabetes
Revita DMR
devices
Medtech

Pages